Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Hyperparathyroidism among atomic bomb survivors in Hiroshima.

Fujiwara S, Sposto R, Ezaki H, Akiba S, Neriishi K, Kodama K, Hosoda Y, Shimaoka K.

Radiat Res. 1992 Jun;130(3):372-8.

PMID:
1594765
2.

Cancer and non-cancer effects in Japanese atomic bomb survivors.

Little MP.

J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. Review.

PMID:
19454804
4.

Effect of radiation dose on the height of atomic bomb survivors: a longitudinal study.

Nakashima E, Fujiwara S, Funamoto S.

Radiat Res. 2002 Sep;158(3):346-51.

PMID:
12175312
5.

Levels of parathyroid hormone and calcitonin in serum among atomic bomb survivors.

Fujiwara S, Sposto R, Shiraki M, Yokoyama N, Sasaki H, Kodama K, Shimaoka K.

Radiat Res. 1994 Jan;137(1):96-103.

PMID:
8265793
6.

Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.

Matsuura M, Hoshi M, Hayakawa N, Shimokata H, Ohtaki M, Ikeuchi M, Kasagi F.

Int J Radiat Biol. 1997 May;71(5):603-11.

PMID:
9191905
7.

Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.

Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant EJ, Sugiyama H, Sakata R, Moriwaki H, Hayashi M, Konda M, Shore RE.

BMJ. 2010 Jan 14;340:b5349. doi: 10.1136/bmj.b5349.

8.

Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985.

Yoshimoto Y, Ezaki H, Etoh R, Hiraoka T, Akiba S.

Radiat Res. 1995 Mar;141(3):278-86.

PMID:
7871154
9.

Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.

Kato K, Antoku S, Russell WJ, Fujita S, Pinkston JA, Hayabuchi N, Hoshi M, Kodama K.

Radiat Res. 1998 Jun;149(6):614-24.

PMID:
9611100
10.

Autoantibodies and immunoglobulins among atomic bomb survivors.

Fujiwara S, Carter RL, Akiyama M, Akahoshi M, Kodama K, Shimaoka K, Yamakido M.

Radiat Res. 1994 Jan;137(1):89-95.

PMID:
8265792
11.

Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K.

Radiat Res. 1996 Jul;146(1):1-27.

PMID:
8677290
12.

Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions.

Yamada M, Izumi S.

Soc Psychiatry Psychiatr Epidemiol. 2002 Sep;37(9):409-15.

PMID:
12242616
13.

Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.

Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al.

Radiat Res. 1994 Feb;137(2 Suppl):S17-67. Review. Erratum in: Radiat Res 1994 Jul;139(1):129.

PMID:
8127952
14.

Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K.

Radiat Res. 2003 Oct;160(4):381-407.

PMID:
12968934
15.

Monitoring exposure to atomic bomb radiation by somatic mutation.

Akiyama M, Kyoizumi S, Kusunoki Y, Hirai Y, Tanabe K, Cologne JB.

Environ Health Perspect. 1996 May;104 Suppl 3:493-6.

16.

Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?

Little MP, Hall P, Charles MW.

Radiat Environ Biophys. 2007 Nov;46(4):299-310. Epub 2007 Jul 17.

PMID:
17639450
17.

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.

Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr.

Radiat Res. 1995 Mar;141(3):259-77.

PMID:
7871153
18.

Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.

Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K.

Prev Med. 1997 Jan-Feb;26(1):144-53.

PMID:
9010910
19.

Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study.

Yamada M, Naito K, Kasagi F, Masunari N, Suzuki G.

Int J Radiat Biol. 2005 Nov;81(11):821-6.

PMID:
16484151
20.

Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.

Iwanaga M, Tagawa M, Tsukasaki K, Matsuo T, Yokota K, Miyazaki Y, Fukushima T, Hata T, Imaizumi Y, Imanishi D, Taguchi J, Momita S, Kamihira S, Tomonaga M.

Blood. 2009 Feb 19;113(8):1639-50. doi: 10.1182/blood-2008-05-159665. Epub 2008 Oct 10.

Supplemental Content

Support Center